FDA Removes Black Box Warnings For Menopause Hormone Therapy

The FDA has removed Black Box Warnings for many menopause hormone therapy products as of late last year. This follows research from the early 2000s that had previously raised alarms regarding hormone replacement therapy. Secretary of Health and Human Services Robert F. Kennedy Jr. is noted in relation to current health advancements. The shift follows decades where the American medical establishment advised against such therapies. This regulatory change is described as part of a larger medical correction to address the historical understudying of women's health. The shift aims to better account for how hormonal changes impact the entire body, including oral health. Policy makers are reportedly pushing for more inclusive care standards. For decades, research in the medical establishment was often built around male bodies, leaving women's health understudied. New evidence is changing the conversation regarding the use of these products. The shift follows a period where usage was being driven down.